FDA Center for Drug Evaluation & Research Issues Warning Letter to Northland Nuclear Medicine
October 28, 2026
October 28, 2026
WASHINGTON, Oct. 28 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Northland Nuclear Medicine LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Nathan J. Fleck, Pharm.D., President & Owner, Northland Nuclear Medicine, LLC, 1815 Michigan Ave., Bismarck, ND 58504-6121, United States
(b)(4)
Issuing Office: Center for Drug Evaluation and Rese . . .
* * *
Recipient: Nathan J. Fleck, Pharm.D., President & Owner, Northland Nuclear Medicine, LLC, 1815 Michigan Ave., Bismarck, ND 58504-6121, United States
(b)(4)
Issuing Office: Center for Drug Evaluation and Rese . . .